284 results on '"Uhlmann, Wendy R."'
Search Results
2. Health care utilization and behavior changes after workplace genetic testing at a large US health care system
3. The Michigan Genetic Hereditary Testing (MiGHT) study’s innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial
4. Tools for communicating risk for Parkinson’s disease
5. Voluntary workplace genomic testing: wellness benefit or Pandora’s box?
6. The persistent lack of knowledge and misunderstanding of the Genetic Information Nondiscrimination Act (GINA) more than a decade after passage
7. Genetic testing for neurodegenerative diseases: Ethical and health communication challenges
8. Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today
9. Getting personal: Head and neck cancer management in the era of genomic medicine.
10. Response to "assessment of risk of ALS conferred by the GGGGCC hexanucleotide expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion".
11. Application of a framework to guide genetic testing communication across clinical indications
12. Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants
13. Chapter 17 - Genetic counseling
14. Genetic Testing of HTT Modifiers for Huntington's Disease: Considerations for Clinical Guidelines
15. List of contributors
16. Genetic counseling
17. List of contributors
18. Genetic counseling for adults
19. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone
20. Direct-to-Consumer Genetic Testing : User Motivations, Decision Making, and Perceived Utility of Results
21. Incorporating Genetic Testing Into the Care of Patients With Amyotrophic Lateral Sclerosis/Frontotemporal Degeneration Spectrum Disorders
22. Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today
23. Correction: The persistent lack of knowledge and misunderstanding of the Genetic Information Nondiscrimination Act (GINA) more than a decade after passage
24. Interpretations of the Term “Actionable” when Discussing Genetic Test Results: What you Mean Is Not What I Heard
25. Ethical issues in neurogenetics
26. Primary Care Providers' Initial Evaluation of Children with Global Developmental Delay: A Clinical Vignette Study
27. The Genetics Journey: A Case Report of a Genetic Diagnosis Made 30 Years Later
28. Development of a Streamlined Work Flow for Handling Patients’ Genetic Testing Insurance Authorizations
29. Utilization of Genetic Counseling after Direct-to-Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study
30. Public’s Views toward Return of Secondary Results in Genomic Sequencing: It’s (Almost) All about the Choice
31. Effect of Public Deliberation on Attitudes toward Return of Secondary Results in Genomic Sequencing
32. How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study
33. List of Contributors
34. Prenatal Testing for Adult-Onset Conditions: the Position of the National Society of Genetic Counselors
35. 2013 Review and Update of the Genetic Counseling Practice Based Competencies by a Task Force of the Accreditation Council for Genetic Counseling
36. Searching for Answers: Information-Seeking by Young People At-Risk for Huntington’s Disease
37. The goldilocks conundrum: Disclosing discrimination risks in informed consent
38. Recommendations for returning genomic incidental findings? We need to talk!
39. Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues
40. A Marfan syndrome-like phenotype caused by a neocentromeric supernumerary ring chromosome 15
41. Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease
42. Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk
43. Direct-to-consumer genetic testing: An assessment of genetic counselors' knowledge and beliefs
44. Amyotrophic Lateral Sclerosis in a Patient with a Family History of Huntington Disease: Genetic Counseling Challenges
45. Getting personal: Head and neck cancer management in the era of genomic medicine
46. Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial
47. Genetic Counseling
48. Genetic testing and insurance implications: Surveying the US general population about discrimination concerns and knowledge of the Genetic Information Nondiscrimination Act (GINA)
49. Prompting Primary Care Providers about Increased Patient Risk As a Result of Family History: Does It Work?
50. Biallelic Mutations in Huntington Disease: A New Case with Just one Affected Parent, Review of the Literature and Terminology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.